Back to Directory
113 Botanicals
Founded 2019
Cannabinoid medicines, botanical extraction and controlled-release drug delivery
113 Botanicals is a biopharmaceutical company developing cannabis-derived medicines, botanical extraction technologies and controlled-release drug delivery systems. Its work includes full-spectrum cannabinoid extracts, sustained-release oral capsules and transdermal formulations.
The company collaborates with the University of Sussex on extraction and formulation research, with technologies designed to improve dosing consistency and provide alternative routes for administering medicinal cannabinoids.